Barrier Therapeutics Inc Watch

from 8-K 8 pages Confidential Separation Agreement and General Release

from 8-K 9 pages Confidential Separation Agreement and General Release

from 8-K 14 pages Employment Agreement

from 8-K 14 pages Amended and Restated Employment Agreement

from 10-K 21 pages Third-Party Manufacturing Agreement

from 8-K 6 pages September 21, 2007 Anne Vanlent Executive Vice President, Chief Financial Officer Barrier Therapeutics, Inc. 600 College Road East, Suite 3200 Princeton, Nj 08540-6697 Dear Anne: This Is to Confirm the Agreement (This “Agreement”) Between Pacific Growth Equities, LLC (“Pge” or “Pacific Growth”) and Barrier Therapeutics, Inc. (The “Company”) as Follows

from 10-Q 18 pages Ownership Pledge, Assignment and Security Agreement

from 10-Q 23 pages Supply Agreement

from 10-K 12 pages Sales Force Services Agreement

from 10-K 13 pages Amended and Restated Employment Agreement

from 10-K 13 pages Amended and Restated Employment Agreement

from 10-K 13 pages Amended and Restated Employment Agreement

from 10-K 13 pages Amended and Restated Employment Agreement

from 10-K 13 pages Amended and Restated Employment Agreement

from 10-K 4 pages Re: Amendment No. 1 (This “Amendment”) to the Pharmaceutical Product Supply Agreement Dated January 27, 2005 (The “Agreement”) by and Between Dsm Pharmaceuticals, Inc. (“Dsm”) and Barrier Therapeutics, Inc. (“Barrier”) Dear Mr. Rizzo: This Letter Confirms the Recent Discussions Between Dsm and Barrier Regarding the Proposed Amendment of the Pharmaceutical Product Supply Agreement (The “Agreement”) Referenced Above. All Terms and Conditions Defined Herein Are Used as Defined in the Agreement. This Amendment No. 1 Amends the Specific Terms Referenced Below. 1. Exhibit 1 of Agreement Shall Be Revised to Reflect Changes to the 2005 and 2006 Minimum Quantities and the Product Price for Each Contract Year. the Revised Exhibit 1 Is Attached Hereto and Incorporated Herein by Reference. 2. Section 2.2 of the Agreement Shall Be Amended to Read as Follows

from 10-K 28 pages Manufacturing Agreement Dpt Laboratories, Ltd. and Barrier Therapeutics, Inc

from 10-K 63 pages Pharmaceutical Product Supply Agreement Dated January 27, 2005 by and Between Dsm Pharmaceuticals, Inc. and Barrier Therapeutics, Inc

from 10-Q 4 pages Amendment to the Finished Product Supply Agreement

from 10-Q 7 pages Barrier Therapeutics, Inc. Science Advisory Board Consulting Agreement

from 10-Q 3 pages Amendment No. 2 to Jpplp Intellectual Property Transfer and License Agreement